These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17207198)

  • 1. Annular leukocytoclastic vasculitis in association with chronic hepatitis B.
    Meissner M; Beier C; Gille J; Kaufmann R
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):135-6. PubMed ID: 17207198
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agent.
    Filer A; Hughes A; Kane K; Mutimer D; Jobanputra P
    Rheumatology (Oxford); 2001 Sep; 40(9):1064-5. PubMed ID: 11561121
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral therapy for various stages of HBV-related diseases: lamivudine and beyond.
    Jia JD
    J Gastroenterol Hepatol; 2008 May; 23(5):681-2. PubMed ID: 18410600
    [No Abstract]   [Full Text] [Related]  

  • 4. Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B?
    Su CW; Wu JC; Lee SD
    Hepatology; 2008 Nov; 48(5):1726-7; author reply 1727-8. PubMed ID: 18972445
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
    Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
    J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance after lamivudine therapy for chronic hepatitis B.
    Sarrecchia C; Volpi A; Sordillo P; Andreoni M
    Int J Infect Dis; 2009 May; 13(3):e133-4. PubMed ID: 18990599
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine.
    Kobayashi M; Suzuki F; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Yatsuji H; Kobayashi M; Suzuki Y; Arase Y; Ikeda K; Watahiki S; Iwasaki S; Miyakawa Y; Kumada H
    J Med Virol; 2007 Oct; 79(10):1472-7. PubMed ID: 17705186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection.
    Inoue T; Fuke H; Yamamoto N; Ito K; Yutaka KY; Yamanaka ; Shiraki K
    Hepatogastroenterology; 2007; 54(75):889-91. PubMed ID: 17591085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.
    Schiff E; Simsek H; Lee WM; Chao YC; Sette H; Janssen HL; Han SH; Goodman Z; Yang J; Brett-Smith H; Tamez R
    Am J Gastroenterol; 2008 Nov; 103(11):2776-83. PubMed ID: 18721244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression.
    Yeh CT; Hsu CW; Chen YC; Liaw YF
    J Clin Virol; 2009 Jun; 45(2):114-8. PubMed ID: 19451024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for and treating hepatitis B virus in patients with HIV infection.
    Tillmann HL
    Clin Infect Dis; 2007 Sep; 45(5):633-6. PubMed ID: 17683000
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis.
    Nishida T; Kobashi H; Fujioka S; Fujio K; Takaguchi K; Ikeda H; Kawaguchi M; Ando M; Araki Y; Higashi T; Shoji B; Takaki A; Iwasaki Y; Sakaguchi K; Shiratori Y; Yamamoto K
    J Gastroenterol Hepatol; 2008 May; 23(5):794-803. PubMed ID: 18086120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of cirrhosis of the liver detected by elastiometry.
    Mössner BK; Biagini M; Pedersen C; Christensen PB
    Scand J Gastroenterol; 2008; 43(11):1401-2. PubMed ID: 18615357
    [No Abstract]   [Full Text] [Related]  

  • 16. [Factors related to the outcome of patients with chronic severe hepatitis B and effectiveness of antivirus therapy].
    Wu YZ; Zhao FL; Zhang CZ; Li MH; Xie Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):120-2. PubMed ID: 17653310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lamivudine treatment of a HBs antigen positive man with reactive arthritis].
    Borup C; Siboni A
    Ugeskr Laeger; 2008 Nov; 170(48):3940-1. PubMed ID: 19087731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine.
    Vandepapelière P; Lau GK; Leroux-Roels G; Horsmans Y; Gane E; Tawandee T; Merican MI; Win KM; Trepo C; Cooksley G; Wettendorff M; Ferrari C;
    Vaccine; 2007 Dec; 25(51):8585-97. PubMed ID: 18031872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Week 24 suppression of HBV in entecavir-treated chronic hepatitis B patients in whom lamivudine treatment failed is associated with efficacy at week 48].
    Ma H; Ren JB; Li HY; Wang Y; Wang RL; Liang L; Sun SJ; Jia JD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):102-4. PubMed ID: 17653304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B].
    Kim JM; Choe BH; Chu MA; Cho SM
    Korean J Hepatol; 2009 Jun; 15(2):168-78. PubMed ID: 19581769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.